176 related articles for article (PubMed ID: 22127978)
21. Antiviral gene expression in rheumatoid arthritis: role of IKKepsilon and interferon regulatory factor 3.
Sweeney SE; Mo L; Firestein GS
Arthritis Rheum; 2007 Mar; 56(3):743-52. PubMed ID: 17328045
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
23. Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-α and atherosclerosis in lupus.
Li J; Fu Q; Cui H; Qu B; Pan W; Shen N; Bao C
Arthritis Rheum; 2011 Feb; 63(2):492-502. PubMed ID: 21280004
[TBL] [Abstract][Full Text] [Related]
24. Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation.
Goriely S; Molle C; Nguyen M; Albarani V; Haddou NO; Lin R; De Wit D; Flamand V; Willems F; Goldman M
Blood; 2006 Feb; 107(3):1078-84. PubMed ID: 16219795
[TBL] [Abstract][Full Text] [Related]
25. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
26. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.
Horwitz DA; Gray JD; Behrendsen SC; Kubin M; Rengaraju M; Ohtsuka K; Trinchieri G
Arthritis Rheum; 1998 May; 41(5):838-44. PubMed ID: 9588735
[TBL] [Abstract][Full Text] [Related]
27. A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice.
Wang X; Wei Y; Xiao H; Liu X; Zhang Y; Han G; Chen G; Hou C; Ma N; Shen B; Li Y; Egwuagu CE; Wang R
Eur J Immunol; 2016 Jun; 46(6):1343-50. PubMed ID: 27019190
[TBL] [Abstract][Full Text] [Related]
28. Pin1-Targeted Therapy for Systemic Lupus Erythematosus.
Wei S; Yoshida N; Finn G; Kozono S; Nechama M; Kyttaris VC; Zhen Zhou X; Tsokos GC; Ping Lu K
Arthritis Rheumatol; 2016 Oct; 68(10):2503-13. PubMed ID: 27159270
[TBL] [Abstract][Full Text] [Related]
29. Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia.
Li Y; Chu N; Hu A; Gran B; Rostami A; Zhang GX
Brain; 2007 Feb; 130(Pt 2):490-501. PubMed ID: 17003070
[TBL] [Abstract][Full Text] [Related]
30. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
Oganesyan G; Saha SK; Guo B; He JQ; Shahangian A; Zarnegar B; Perry A; Cheng G
Nature; 2006 Jan; 439(7073):208-11. PubMed ID: 16306936
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
[TBL] [Abstract][Full Text] [Related]
32. Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.
Liu J; Berthier CC; Kahlenberg JM
Arthritis Rheumatol; 2017 Sep; 69(9):1840-1849. PubMed ID: 28564495
[TBL] [Abstract][Full Text] [Related]
33. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.
Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I
J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128
[TBL] [Abstract][Full Text] [Related]
34. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
35. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.
Liu-Bryan R; Scott P; Sydlaske A; Rose DM; Terkeltaub R
Arthritis Rheum; 2005 Sep; 52(9):2936-46. PubMed ID: 16142712
[TBL] [Abstract][Full Text] [Related]
36. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus.
Mellor-Pita S; Citores MJ; Castejon R; Yebra-Bango M; Tutor-Ureta P; Rosado S; Andreu JL; Vargas JA
Cytometry B Clin Cytom; 2009 Jul; 76(4):261-70. PubMed ID: 19199277
[TBL] [Abstract][Full Text] [Related]
37. Interferon regulatory factor 3 deficiency leads to interleukin-17-mediated liver ischemia-reperfusion injury.
Loi P; Yuan Q; Torres D; Delbauve S; Laute MA; Lalmand MC; Pétein M; Goriely S; Goldman M; Flamand V
Hepatology; 2013 Jan; 57(1):351-61. PubMed ID: 22911673
[TBL] [Abstract][Full Text] [Related]
38. Pivotal role of cerebral interleukin-23 during immunologic injury in delayed cerebral ischemia in mice.
Zheng Y; Zhong D; Chen H; Ma S; Sun Y; Wang M; Liu Q; Li G
Neuroscience; 2015 Apr; 290():321-31. PubMed ID: 25637493
[TBL] [Abstract][Full Text] [Related]
39. The 9p21 locus does not affect risk of coronary artery disease through induction of type 1 interferons.
Erridge C; Gracey J; Braund PS; Samani NJ
J Am Coll Cardiol; 2013 Oct; 62(15):1376-81. PubMed ID: 23933542
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2-induced IL-23p19 subunit is regulated by cAMP-responsive element-binding protein and C/AATT enhancer-binding protein β in bone marrow-derived dendritic cells.
Kocieda VP; Adhikary S; Emig F; Yen JH; Toscano MG; Ganea D
J Biol Chem; 2012 Oct; 287(44):36922-35. PubMed ID: 22977257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
